Skip to content

Clinical study to examine the effects of food ingredient extracts in people with mild cognitive impairment

Clinical study to examine the effects of food ingredient extracts in people with mild cognitive impairment - Research to verify the effects of food ingredient extracts

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053369
Enrollment
90
Registered
2025-12-31
Start date
2024-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild cognitive impairment

Interventions

A pre-intervention survey will be conducted on the subjects, and food extract powder will be continuously consumed twice a day, morning and evening, before, 3 months, and 6 months of intake will be co

Sponsors

Tokushima University Graduate School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Elderly persons who are in good health and have maintained their daily functions but have mild cognitive decline, and who have given consent for the study. Those who have an MMSE score between 24 and 27. Gender: male and female Age: 65 years and older Age: 65 years old or older Organ function: No obvious abnormal values in blood tests

Exclusion criteria

Exclusion criteria: (1) Those suffering from serious cerebrovascular disease, cardiac disease, liver disease, renal disease, gastrointestinal disease, or infectious disease requiring notification (2) Those diagnosed with obvious dementia (3) Those with chronic diseases (diabetes, heart disease, liver failure, renal failure, gastric/duodenal ulcer, colitis, Crohn's disease, cancer, etc.) who are receiving treatment or medication (4) Persons with familial hypercholesterolemia (5) Those with significant abnormalities in blood pressure measurements or blood tests (6) Patients with severe anemia or bleeding tendency (7) Persons with frequent symptoms of diarrhea (8) Persons who may show allergic symptoms to the test sample (9) Patients who are regular users of excessive smoking and alcohol, and those who have extremely irregular lifestyles in terms of diet, sleep, etc. (10)Persons who are currently participating or have participated within one month in other clinical trials. (11)Other subjects who are judged to be ineligible by the study sponsor. Translated with www.DeepL.com/Translator (free version)

Design outcomes

Primary

MeasureTime frame
MMSE (Cognitive function test)

Secondary

MeasureTime frame
Evaluation using a brain activity balancer Height, weight, body composition Taste test (Taste Disc) Survey of motivation for daily life using Q-ESD Survey of lifestyle and eating habits using FFQ Time up and Go to test Grip strength Oral microflora test using saliva sampling

Countries

Japan

Contacts

Public ContactHiroshi sakaue

Tokushima University Graduate Schoo Institute of Biomedical sciences

hsakaue@tokushima-u.ac.jp0886339249

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026